Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
The return on assets (ROA) is N/A as of Tuesday, October 6, 2026.
RETURN ON ASSETS (ROA)
N/A
Latigo Biotherapeutics Inc.
Market Cap
$978.09M
Return on Assets (ROA)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$981.66M
Return on Assets (ROA)
19.92%
TTM Avg
-50.75%
3Y Avg
-41.99%
5Y Avg
-34.79%
Market Cap
$982.46M
Return on Assets (ROA)
-23.69%
TTM Avg
-98.11%
3Y Avg
-69.18%
5Y Avg
-69.18%
Market Cap
$973.93M
Return on Assets (ROA)
1.18%
TTM Avg
-2.92%
3Y Avg
-0.56%
5Y Avg
1.87%
Market Cap
$992.14M
Return on Assets (ROA)
130.50%
TTM Avg
-115.89%
3Y Avg
-79.68%
5Y Avg
-67.37%
Market Cap
$996.65M
Return on Assets (ROA)
-22.90%
TTM Avg
-17.96%
3Y Avg
-22.57%
5Y Avg
-25.02%
Market Cap
$998.69M
Return on Assets (ROA)
-56.27%
TTM Avg
-37.98%
3Y Avg
-21.94%
5Y Avg
-21.15%
Market Cap
$953.81M
Return on Assets (ROA)
-13.12%
TTM Avg
-18.77%
3Y Avg
-18.48%
5Y Avg
-18.48%
Market Cap
$952.91M
Return on Assets (ROA)
-72.50%
TTM Avg
-45.97%
3Y Avg
-37.50%
5Y Avg
-37.52%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Latigo Biotherapeutics Inc. (LTGO) | $978.09M | N/A | N/A | N/A | N/A |
| MeiraGTx Holdings plc (MGTX)vs › | $981.66M | 19.92% | -50.75% | -41.99% | -34.79% |
| LB Pharmaceuticals Inc Common Stock (LBRX)vs › | $982.46M | -23.69% | -98.11% | -69.18% | -69.18% |
| Pacira BioSciences, Inc. (PCRX)vs › | $973.93M | 1.18% | -2.92% | -0.56% | 1.87% |
| Vor Biopharma Inc. (VOR)vs › | $992.14M | 130.50% | -115.89% | -79.68% | -67.37% |
| PROCEPT BioRobotics Corporation (PRCT)vs › | $996.65M | -22.90% | -17.96% | -22.57% | -25.02% |
| Cullinan Therapeutics, Inc. (CGEM)vs › | $998.69M | -56.27% | -37.98% | -21.94% | -21.15% |
| Aktis Oncology, Inc. (AKTS)vs › | $953.81M | -13.12% | -18.77% | -18.48% | -18.48% |
| Savara Inc. (SVRA)vs › | $952.91M | -72.50% | -45.97% | -37.50% | -37.52% |
| Immatics N.V. (IMTX)vs › | $1.01B | -43.17% | -16.38% | -11.13% | -30.16% |
ROA
N/A
ROE
N/A
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
